financing

News

Heather Turner, LB Pharma's chief executive.

After a long biotech IPO lull, LB Pharma chances its arm

After a promising start, IPOs all but fizzled out this year, but LB Pharma is hoping that won't stymy its chances of completing a Nasdaq listing.

News

NRG raises £50m to start trials of Parkinson's, ALS drug

NRG Therapeutics' oversubscribed Series B will fund first-in-human trials of a drug targeting mitochondrial dysfunction in neurodegenerative diseases.

News

Treeline's $200m Series A extension, and other biofinancings

Recent biotech financings include a $200m round for Treeline, with Enveda, Wugen, CHARM Therapeutics, and MRM Health also in on the action.

News

Twin Health raises $53m, as study backs 'digital twin' AI

Twin Health has raised $53m to fund further rollout of its digital twin AI, shown to improve glucose control in diabetics in a just-published study.

News

Strand raises $153m for RNA meds, and other bio financings

Recent financings in biotech include a $153m Series B for programmable mRNA developer Strand, plus rounds for Artbio, Minghui, and Chai Discovery.

News

#InvestinBiotech yearly honeycomb on green background

UK biotech investment "holding firm", says BIA

The UK life sciences raised £1.23bn in venture capital investment in the first half of 2025, although there was a fallback in the second quarter.

After a long biotech IPO lull, LB Pharma chances its arm

NRG raises £50m to start trials of Parkinson's, ALS drug

Treeline's $200m Series A extension, and other biofinancings

Twin Health raises $53m, as study backs 'digital twin' AI

Strand raises $153m for RNA meds, and other bio financings

UK biotech investment "holding firm", says BIA

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

financing

Editor's Picks